These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2986440)

  • 21. Angiotensin-converting enzyme inhibition in congestive heart failure: the concept.
    Cohn JN; Levine TB
    Am J Cardiol; 1982 Apr; 49(6):1480-3. PubMed ID: 6176108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemodynamic and antihypertensive effects of the new oral angiotensin-converting-enzyme inhibitor MK-421 (enalapril).
    Fouad FM; Tarazi RC; Bravo EL; Textor SC
    Hypertension; 1984; 6(2 Pt 1):167-74. PubMed ID: 6327515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of a long-acting converting enzyme inhibitor (enalapril) for the treatment of chronic congestive heart failure.
    Cody RJ; Covit AB; Schaer GL; Laragh JH
    J Am Coll Cardiol; 1983 Apr; 1(4):1154-9. PubMed ID: 6187789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of inhibition of angiotensin I conversion by three converting enzyme inhibitors in rats.
    Takata Y; Di Nicolantonio R; Hutchinson JS
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():129-34. PubMed ID: 6183035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of hypertension with angiotensin converting enzyme inhibitors.
    Johnston CI; McGrath BP; Matthews PG; Jackson B
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():135-44. PubMed ID: 6183036
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical pharmacokinetics of the angiotensin converting enzyme inhibitors. A review.
    Kubo SH; Cody RJ
    Clin Pharmacokinet; 1985; 10(5):377-91. PubMed ID: 2994938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Converting enzyme inhibitors in hemodialysis.
    Bazilinski N
    Int J Artif Organs; 1983 Mar; 6(2):62-4. PubMed ID: 6302010
    [No Abstract]   [Full Text] [Related]  

  • 28. Angiotensin-converting enzyme inhibitors.
    Dipalma JR
    Am Fam Physician; 1980 Nov; 22(5):164-5. PubMed ID: 6158857
    [No Abstract]   [Full Text] [Related]  

  • 29. Plasma enalapril levels and hormonal effects after short- and long-term administration in essential hypertension.
    Johnston CI; Jackson BJ; Larmour I; Cubella R; Casley D
    Br J Clin Pharmacol; 1984; 18 Suppl 2(Suppl 2):233S-239S, 241S. PubMed ID: 6099738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between angiotensin I blockade and antihypertensive properties of single doses of MK-421 and captopril in spontaneous and renal hypertensive rats.
    Sweet CS; Arbegast PT; Gaul SL; Blaine EH; Gross DM
    Eur J Pharmacol; 1981 Dec; 76(2-3):167-76. PubMed ID: 6174351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of enalapril, a new converting enzyme inhibitor, in hypertension.
    Ferguson RK; Vlasses PH; Swanson BN; Mojaverian P; Hichens M; Irvin JD; Huber PB
    Clin Pharmacol Ther; 1982 Jul; 32(1):48-53. PubMed ID: 6282527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of the new oral angiotensin converting enzyme inhibitor MK-421 in human hypertension.
    Gavras H; Biollaz J; Waeber B; Brunner HR; Gavras I; Davies RO
    Clin Exp Hypertens A; 1982; 4(1-2):303-14. PubMed ID: 6280900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resolution of captopril-induced rash after substitution of enalapril.
    Rotmensch HH; Vlasses PH; Ferguson RK
    Pharmacotherapy; 1983; 3(2 Pt 1):131-3. PubMed ID: 6304662
    [No Abstract]   [Full Text] [Related]  

  • 34. Enalapril (MK-421), a new angiotensin-converting enzyme inhibitor. Acute and chronic effects in heart failure.
    Dunkman WB; Wilen M; Franciosa JA
    Chest; 1983 Nov; 84(5):539-45. PubMed ID: 6313304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiotensin converting enzyme inhibitors. Disparities in the mechanism of their antihypertensive effect.
    Garavaglia GE; Messerli FH; Nunez BD; Schmieder RE; Frohlich ED
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):214S-216S. PubMed ID: 2843195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical application of renin inhibitors in the treatment of hypertension].
    Hiwada K
    Nihon Rinsho; 1989 Sep; 47(9):2041-6. PubMed ID: 2687512
    [No Abstract]   [Full Text] [Related]  

  • 37. Role of angiotensin and its inhibition in hypertension, ischemic heart disease, and heart failure.
    Gavras H; Brunner HR
    Hypertension; 2001 Feb; 37(2 Pt 2):342-5. PubMed ID: 11230297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An overview of the clinical pharmacology of enalapril.
    Davies RO; Gomez HJ; Irvin JD; Walker JF
    Br J Clin Pharmacol; 1984; 18 Suppl 2(Suppl 2):215S-229S. PubMed ID: 6099737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemodynamic effects of the converting enzyme inhibitor teprotide in normal- and high-renin hypertension.
    Niarchos AP; Pickering TG; Wallace JM; Case DB; Laragh JH
    Clin Pharmacol Ther; 1980 Nov; 28(5):592-601. PubMed ID: 6160013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin inhibitors for hypertension.
    Gavras H; Gavras I; Brunner HR
    Compr Ther; 1980 May; 6(5):14-8. PubMed ID: 6155240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.